Key Takeaway: Dr. Sarah Kolitz has joined the team, bringing valuable expertise in biological mechanisms. She completed her postdoctoral research in Biological Engineering at MIT and holds a Ph.D. in Biophysics and Biophysical Chemistry from Johns Hopkins University. Her background is expected to enhance the team's capabilities.
Price reaction · baseline $6.73 (2025-12-26 close) · 28 other IMRX headline(s) in the window, move may be shared
day 0 close · peak
-1%
Market Sentiment Analysis
POSITIVE FACTORS
Dr. Kolitz has extensive expertise in biological mechanisms.
She has a strong academic background from prestigious institutions.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+41%
120-day peak, hindsight
Typical move
11.4%
average across 8 past catalysts
Cash runway
~36 mo
Minimal dilution risk
Lead asset
IMM-1-104 Monotherapy
Phase 1 · Advanced Solid Tumor
Full Press Release Details
Dr. Kolitz brings expertise in teasing apart biological mechanisms to our team. She conducted her postdoctoral research in Biological Engineering at the Massachusetts Institute of Technology, after earning a Ph.D. in Biophysics and Biophysical Chemistry from the Johns Hopkins University School of Medicine.
Frequently Asked Questions
What is Dr. Kolitz's area of expertise?
Dr. Kolitz specializes in understanding biological mechanisms.
Where did Dr. Kolitz conduct her postdoctoral research?
She conducted her postdoctoral research at the Massachusetts Institute of Technology.
What degree does Dr. Kolitz hold?
Dr. Kolitz holds a Ph.D. in Biophysics and Biophysical Chemistry.
Which university did Dr. Kolitz attend for her Ph.D.?
She earned her Ph.D. from the Johns Hopkins University School of Medicine.